Sung Key Jang

Title: The Innovative Contributions of Sung Key Jang

Introduction

Sung Key Jang is a notable inventor based in Kyungbuk, South Korea. He has made significant contributions to the field of virology, particularly in the study of hepatitis C virus (HCV). His work has implications for antiviral drug development and understanding viral replication mechanisms.

Latest Patents

Sung Key Jang holds a patent for an "Efficient hepatitis C virus replicon and its use in identifying antiviral compounds." This invention provides a Hepatitis C Virus (HCV) replicon that efficiently replicates in eukaryotic cells. The replicon includes a nucleic acid sequence encoding subgenomic fragments of HCV of any genotype, which confer the ability to replicate. Additionally, it features a nucleic acid sequence encoding an acetyl transferase selectable marker, such as puromycin. The invention also includes eukaryotic cell lines that contain the HCV replicon, which can be used for screening candidate compounds that inhibit HCV propagation. Sung Key Jang has 1 patent to his name.

Career Highlights

Sung Key Jang is affiliated with the State University of New York, where he continues to advance research in virology. His work has been instrumental in developing tools for studying HCV, which is a significant public health concern worldwide.

Collaborations

He has collaborated with notable researchers in the field, including Eckard Wimmer and Chengyu Liang. These collaborations have further enhanced the impact of his research and contributed to advancements in antiviral therapies.

Conclusion

Sung Key Jang's innovative work in developing an efficient HCV replicon has opened new avenues for antiviral research. His contributions are vital for the ongoing fight against hepatitis C and highlight the importance of collaboration in scientific advancements.